CLINICAL_TRIALS
trial_result
· 2013-12-18
Clinical Trial Update: Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder [Phase 3]
Summary
Phase 3 trial evaluating the efficacy of vortioxetine for generalized anxiety disorder; results were posted in December 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-12-18